Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03726086 · ClinicalTrials.gov registry record

Post-extubation Assessment of Laryngeal Symptoms and Severity

A clinical trial, sponsored by Johns Hopkins University.

Completed
Registry status
365
Enrollment target

NCT03726086: Completed study, sponsored by Johns Hopkins University.

NCT03726086 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 365 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03726086 has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
365 participants
Enrollment target

Study Summary

The goal of this study is to learn more about voice and airway problems that patients experience during and after the time patients have an oral endotracheal tube in patients' airway to help patients breathe while receiving mechanical ventilation in an intensive care unit (ICU).

Primary Outcome

Characterize injuries to the larynx and surrounding tissues/anatomy after mechanical ventilation is no longer required and the oral endotracheal tube is removed. Injuries will be graded on a 4-point categorical scale ranging from 0 (no injury) to 3 (severe injury).

Interventions

  • DIAGNOSTIC_TEST laryngoscopy

Trial Details

FieldValue
Enrollment Target 365 participants
Start Date 2019-02-12
Est. Completion 2023-06-10
Johns Hopkins University

1,448 total trials

What the finished NCT03726086 record still lists

NCT03726086 is an observational study that tracks outcomes without assigning an intervention. The registered 365 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which laryngoscopy is the first listed.

NCT03726086 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03726086 about?

NCT03726086 is a clinical study titled "Post-extubation Assessment of Laryngeal Symptoms and Severity". The goal of this study is to learn more about voice and airway problems that patients experience during and after the time patients have an oral endotracheal tube in patients' airway to help patients breathe while receiving mechanical ventilation in an intensive care unit (ICU).

What is the current status of trial NCT03726086?

This trial is currently completed. The enrollment target is 365 participants. The study started on 2019-02-12. Estimated completion is 2023-06-10.

What interventions are being tested in trial NCT03726086?

The interventions under investigation include: laryngoscopy (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03726086?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04049604 · 365 participants · NA

    IDENTIFY Study: Natural History of Maternal Neoplasia

  • NCT05065840 · 365 participants · NA

    Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study

  • NCT05303519 · 365 participants · Phase 3

    SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • NCT05592626 · 365 participants · Phase 1

    A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03726086, the US trial registry maintained by the National Library of Medicine. NCT03726086 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.